Clinical Trial Update: Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating varenicline on cognition, safety, tolerability and pharmacokinetics in mild-to-moderate Alzheimer's disease was completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-11-22